272 related articles for article (PubMed ID: 21622266)
1. HRP and prorenin: focus on the (pro)renin receptor and vacuolar H+-ATPase.
Lu X; Danser AH; Meima ME
Front Biosci (Schol Ed); 2011 Jun; 3(4):1205-15. PubMed ID: 21622266
[TBL] [Abstract][Full Text] [Related]
2. The (pro)renin receptor. A decade of research: what have we learned?
Krop M; Lu X; Danser AH; Meima ME
Pflugers Arch; 2013 Jan; 465(1):87-97. PubMed ID: 22543358
[TBL] [Abstract][Full Text] [Related]
3. Prorenin is the endogenous agonist of the (pro)renin receptor. Binding kinetics of renin and prorenin in rat vascular smooth muscle cells overexpressing the human (pro)renin receptor.
Batenburg WW; Krop M; Garrelds IM; de Vries R; de Bruin RJ; Burcklé CA; Müller DN; Bader M; Nguyen G; Danser AH
J Hypertens; 2007 Dec; 25(12):2441-53. PubMed ID: 17984666
[TBL] [Abstract][Full Text] [Related]
4. The Role of the (Pro)renin Receptor in Hypertensive Disease.
Danser AH
Am J Hypertens; 2015 Oct; 28(10):1187-96. PubMed ID: 25890829
[TBL] [Abstract][Full Text] [Related]
5. Current knowledge of (pro)renin receptor as an accessory protein of vacuolar H+-ATPase.
Ichihara A; Kinouchi K
J Renin Angiotensin Aldosterone Syst; 2011 Dec; 12(4):638-40. PubMed ID: 22147806
[TBL] [Abstract][Full Text] [Related]
6. Prorenin uptake in the heart: a prerequisite for local angiotensin generation?
Jan Danser AH; Saris JJ
J Mol Cell Cardiol; 2002 Nov; 34(11):1463-72. PubMed ID: 12431445
[TBL] [Abstract][Full Text] [Related]
7. (Pro)renin receptor as a therapeutic target for the treatment of cardiovascular diseases?
Sun Y; Danser AHJ; Lu X
Pharmacol Res; 2017 Nov; 125(Pt A):48-56. PubMed ID: 28532817
[TBL] [Abstract][Full Text] [Related]
8. Biochemical properties of renin and prorenin binding to the (pro)renin receptor.
Nabi AH; Suzuki F
Hypertens Res; 2010 Feb; 33(2):91-7. PubMed ID: 19942927
[TBL] [Abstract][Full Text] [Related]
9. (Pro)renin receptor and insulin resistance: possible roles of angiotensin II-dependent and -independent pathways.
Rafiq K; Mori H; Masaki T; Nishiyama A
Mol Cell Endocrinol; 2013 Sep; 378(1-2):41-5. PubMed ID: 22684035
[TBL] [Abstract][Full Text] [Related]
10. The (pro)renin receptor as a pharmacological target in cardiorenal diseaes.
Funke-Kaiser H; Unger T
Hypertens Res; 2023 Nov; 46(11):2527-2534. PubMed ID: 37667044
[TBL] [Abstract][Full Text] [Related]
11. The (pro)renin receptor and the mystic HRP--is there a role in cardiovascular disease?
Maschke U; Muller DN
Front Biosci (Elite Ed); 2010 Jun; 2(4):1250-3. PubMed ID: 20515798
[TBL] [Abstract][Full Text] [Related]
12. The (pro)renin receptor and its interaction partners.
Peters J
Pflugers Arch; 2017 Oct; 469(10):1245-1256. PubMed ID: 28620832
[TBL] [Abstract][Full Text] [Related]
13. The (pro)renin receptor: a new addition to the renin-angiotensin system?
Batenburg WW; Jan Danser AH
Eur J Pharmacol; 2008 May; 585(2-3):320-4. PubMed ID: 18417113
[TBL] [Abstract][Full Text] [Related]
14. The (pro)renin receptor/ATP6AP2 is essential for vacuolar H+-ATPase assembly in murine cardiomyocytes.
Kinouchi K; Ichihara A; Sano M; Sun-Wada GH; Wada Y; Kurauchi-Mito A; Bokuda K; Narita T; Oshima Y; Sakoda M; Tamai Y; Sato H; Fukuda K; Itoh H
Circ Res; 2010 Jul; 107(1):30-4. PubMed ID: 20570919
[TBL] [Abstract][Full Text] [Related]
15. (Pro)renin receptor and V-ATPase: from Drosophila to humans.
Rousselle A; Sihn G; Rotteveel M; Bader M
Clin Sci (Lond); 2014 Apr; 126(8):529-36. PubMed ID: 24400720
[TBL] [Abstract][Full Text] [Related]
16. (Pro)renin receptor is required for prorenin-dependent and -independent regulation of vacuolar H⁺-ATPase activity in MDCK.C11 collecting duct cells.
Lu X; Garrelds IM; Wagner CA; Danser AH; Meima ME
Am J Physiol Renal Physiol; 2013 Aug; 305(3):F417-25. PubMed ID: 23698123
[TBL] [Abstract][Full Text] [Related]
17. Physiology of the (pro)renin receptor: Wnt of change?
Sihn G; Rousselle A; Vilianovitch L; Burckle C; Bader M
Kidney Int; 2010 Aug; 78(3):246-56. PubMed ID: 20505655
[TBL] [Abstract][Full Text] [Related]
18. The (Pro)renin receptor: site-specific and functional linkage to the vacuolar H+-ATPase in the kidney.
Advani A; Kelly DJ; Cox AJ; White KE; Advani SL; Thai K; Connelly KA; Yuen D; Trogadis J; Herzenberg AM; Kuliszewski MA; Leong-Poi H; Gilbert RE
Hypertension; 2009 Aug; 54(2):261-9. PubMed ID: 19546380
[TBL] [Abstract][Full Text] [Related]
19. Combined renin inhibition/(pro)renin receptor blockade in diabetic retinopathy--a study in transgenic (mREN2)27 rats.
Batenburg WW; Verma A; Wang Y; Zhu P; van den Heuvel M; van Veghel R; Danser AH; Li Q
PLoS One; 2014; 9(6):e100954. PubMed ID: 24968134
[TBL] [Abstract][Full Text] [Related]
20. Deterioration of kidney function by the (pro)renin receptor blocker handle region peptide in aliskiren-treated diabetic transgenic (mRen2)27 rats.
te Riet L; van den Heuvel M; Peutz-Kootstra CJ; van Esch JH; van Veghel R; Garrelds IM; Musterd-Bhaggoe U; Bouhuizen AM; Leijten FP; Danser AH; Batenburg WW
Am J Physiol Renal Physiol; 2014 May; 306(10):F1179-89. PubMed ID: 24694588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
